Yasemin Nicola Sakay
Medical News Today
United Kingdom
Contact Yasemin
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Yasemin:
In Conversation: Is the ketogenic diet right for autoimmune conditions?
In this episode of our podcast, Medical News Today explores the potential benefits and drawbacks of being on a ketogenic diet for the management of chronic pain and inflammation arising from autoimmune conditions. → Read More
Dementia: Correcting age-related hearing loss may reduce risk by 19%
New research suggests that using hearing aids or having a cochlear implant to treat age-related hearing loss may reduce a person's risk of developing dementia. → Read More
In Conversation: How Viagra became a new 'tool' for young men
In this feature, we discuss how erectile dysfunction pills like Viagra became a weekend drug and new 'tool' for young males, and the many reasons behind this behavior. → Read More
Common norovirus infection may be a trigger for Crohn's disease
* Researchers investigated the effects of norovirus on mouse models of Crohn’s disease. * They found that norovirus disables the secretion of a protein that protects against Crohn’s disease. * They concluded that should their findings translate over to humans, researchers may be able to develop new therapeutics for Crohn’s disease. Crohn’s disease is a chronic condition characterized by… → Read More
In Conversation: How to understand chronic pain
Chronic pain, a disease process that is so complex that we are only just beginning to understand its triggers, has recently been gaining recognition as a medical condition on its own. But how does living with chronic pain feel? And how do the body and brain deal with it? Aching, dull, gnawing, burning, sharp, shooting, piercing… These are just some of the words people tend to use to describe… → Read More
UK approves Omicron-updated Moderna COVID-19 booster vaccine
* The United Kingdom has become the first country to approve Moderna’s bivalent COVID-19 vaccine. * The vaccine was developed to target both the original strain and Omicron BA.1 variant of SARS-CoV-2, the virus that causes COVID-19. * The Joint committee on Vaccination and Immunisation (JVCI) will decide how the new vaccine will be offered and if it will be included in its wider fall… → Read More
In Conversation: The amazing story of hepatitis C, from discovery to cure
Medical News Today speaks to an expert and a former patient to discuss the past and future of hepatitis C cures, treatment, and prevention on the occasion of World Hepatitis Day. → Read More
Can psychedelics shift the future of anxiety and depression treatment?
For Medical News Today's In Conversation podcast for May, we delve into research on the future of mental health, with a focus on psychedelics and ketamine as possible treatment avenues for anxiety and depression. → Read More
Moderna's new COVID-19 booster protects better against Omicron, other variants
Moderna's first bivalent COVID-19 booster vaccine candidate has produced better immune responses against several variants, including Omicron. → Read More
Genetic treatment makes skin cells up to 40 years younger
A technique similar to that behind Dolly the cloned sheep can make skin cells up to 40 years younger, according to the latest proof-of-concept research. → Read More
The 'life-saving' science behind gender-affirming care for youth
Research demonstrates that having access to many forms of gender-affirming care is crucial for the mental health and well-being of trans and nonbinary youth. → Read More
COVID-19 booster after Omicron: Are 3rd or 4th shots necessary?
Medical News Today explores why a third or fourth COVID-19 shot is—or isn't—necessary and whether Omicron infection can provide enough protection on its own. → Read More
Beyond Omicron: How vaccines, transmission will shape the next variant
Whether the next SARS-CoV-2 variant after Omicron will be more or less infectious or even vaccine-resistant is a tricky question to answer. → Read More
UK data sheds light on long COVID: Groups at risk, Omicron, and more
According to the latest data, 2.1% of the U.K. population has been experiencing long COVID, and the number of people with it continues to rise. → Read More
Predicting long COVID: Study finds 4 risk factors
A new study suggests that four factors, including having type 2 diabetes, may increase the risk of long COVID. → Read More
Blood donation: A donor, a recipient, and an expert share experiences
An expert from the Red Cross, a super donor, and a recipient discuss their perspectives on and experiences with blood donation for National Blood Donor Month. → Read More
Spinach teeth, soapy cilantro: The science behind weird food phenomena
In this feature, nutritionists explain why cilantro tastes like soap to some, why orange juice and toothpaste do not mix, and more. → Read More
Study shows how vitamin D could halt lung inflammation in COVID-19
A new study reveals the mechanism of how vitamin D may help to combat the hyper-inflammation caused by immune cells in COVID-19. → Read More
Outdoor exercise lessened anxiety, depression during COVID-19 lockdowns
People who stayed physically active and spent more time outdoors during the initial COVID-19 lockdowns in 2020 had better mental health, according to a new study. → Read More
Crohn's and the second brain: Study identifies serotonin as trigger
A new study suggests that serotonin could disrupt gut microbiota and cause Crohn's disease flare-ups. → Read More